Downloadable summaries of the HAWK and HARRIER Phase III clinical trials.
Clinical Trials Summary
Both trials have been summarised in handy one-pagers for quick reference and understanding.
See how Novartis is responding to Coronavirus (COVID-19)
This site is intended for UK healthcare professionals only. If you are a member of the public, please click here
Downloadable summaries of the HAWK and HARRIER Phase III clinical trials.
Clinical Trials Summary
Both trials have been summarised in handy one-pagers for quick reference and understanding.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]